Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01552967
What this trial is testing

Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma

Who this might be right for
Colorectal Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01024504
What this trial is testing

Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hellenic Oncology Research Group 46
Post-approval studies (Phase 4)Not Yet RecruitingNCT07094893
What this trial is testing

Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 280
Testing effectiveness (Phase 2)UnknownNCT01067053
What this trial is testing

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.

Who this might be right for
Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 69
Testing effectiveness (Phase 2)Ended earlyNCT00717990
What this trial is testing

Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment

Who this might be right for
Metastatic Colorectal Cancer
University Hospital of Crete 15
Large-scale testing (Phase 3)Study completedNCT03511963
What this trial is testing

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai Henlius Biotech 677
Not applicableLooking for participantsNCT06938971
What this trial is testing

Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH)

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Rigshospitalet, Denmark 150
Large-scale testing (Phase 3)Study completedNCT01219920
What this trial is testing

FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 244
Testing effectiveness (Phase 2)Ended earlyNCT00838578
What this trial is testing

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin Co., Ltd. 65
Testing effectiveness (Phase 2)Study completedNCT01111604
What this trial is testing

Ramucirumab or Icrucumab in Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Eli Lilly and Company 158
Large-scale testing (Phase 3)UnknownNCT01249638
What this trial is testing

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Who this might be right for
Colorectal Cancer Metastatic
Ludwig-Maximilians - University of Munich 516
Testing effectiveness (Phase 2)Study completedNCT00227734
What this trial is testing

Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 74
Testing effectiveness (Phase 2)Study completedNCT01802684
What this trial is testing

OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 49
Early research (Phase 1)Ended earlyNCT03176264
What this trial is testing

PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Novartis Pharmaceuticals 1
Testing effectiveness (Phase 2)Ended earlyNCT00251186
What this trial is testing

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Who this might be right for
Colorectal Cancer
University of Medicine and Dentistry of New Jersey 18
Not applicableStudy completedNCT03914170
What this trial is testing

Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 70
Large-scale testing (Phase 3)Active Not RecruitingNCT03828227
What this trial is testing

QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.

Who this might be right for
Elderly PatientsMetastatic Colorectal CancerQuality of Life
GERCOR - Multidisciplinary Oncology Cooperative Group 49
Large-scale testing (Phase 3)Study completedNCT00272051
What this trial is testing

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Who this might be right for
MetastasesColorectal NeoplasmsColorectal Carcinoma
Sanofi 620
Testing effectiveness (Phase 2)Study completedNCT01077739
What this trial is testing

Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 75
Testing effectiveness (Phase 2)UnknownNCT01322178
What this trial is testing

Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 90
Next Page